ORAGENICS INC OGEN Cash Flow

Oragenics inc (OGEN)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Net loss
-5,187	-3,597	-3,836	-4,806	-3,325	-2,755	-2,757	-2,281	-2,119	-1,460	-2,067	-1,220	-1,982	-	-	-	-2,062	-2,219	-1,863	-6,335	-1,292	-1,223	-1,029	-1,895	-1,640	-3,079	-9,325	-2,074	-1,589	-1,988	-2,555	-6,928	-1,616	-1,939	-1,807	-2,373	-1,559
Adjustments to reconcile net loss to net cash used in operating activities:
Accretion of discount on notes payable to shareholder
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	443	32	7	-	-	-	-
Depreciation and amortization
13	18	18	13	12	11	7	3	7	12	17	17	18	19	18	18	18	18	20	18	13	7	6	6	6	12	21	21	20	19	18	17	19	-	-	-	-
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	20
Stock-based compensation expense
865	-	-	-	145	-	-	-	-	-	-	-	-	-	-	-	-	-	206	208	46	-	-	-	-	-	-	78	7	223	799	-3	261	203	212	727	118
Stock issued as compensation to non-employee directors
-	-	-	-	-	-	-	-	-	8	20	40	53	67	0	42	42	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation expense
-	-	-	-	-	-	-	81	118	129	106	82	118	102	225	-4	163	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock issued in exchange for services
-	0	0	6	6	-	-	-	-	-	-	-	-	-	-	-	-	-	66	66	66	0	0	96	5	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Accounts receivable, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13	-10	3	-20	-21	5	9	-5	-14	-2	32	-23	-29	48	-10	-40	-27
Income tax receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-362
Inventory, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-62	175	24	-26	-22	305	-79	-54	-6	-155	-73	-9	-112	10	-35	225	8
Prepaid expenses and other current assets
-241	14	-54	-1,368	-18	64	187	534	-333	257	111	411	-66	-30	-51	-23	-123	37	-27	-44	-35	-102	-31	-9	-71	-51	-75	-15	-61	-14	-0	28	-39	-54	-32	-31	-34
Accounts payable and accrued expenses
245	-353	153	-234	931	-323	-170	425	293	208	533	-41	-174	490	92	-233	95	201	205	143	-200	105	-98	-104	-102	45	-345	140	-75	47	-106	-10	11	196	-67	299	-203
Net cash used in operating activities
-3,822	-3,936	-3,377	-3,487	-2,210	-2,977	-2,454	-2,280	-1,366	-1,358	-1,339	-1,765	-1,900	-1,964	-1,571	-1,920	-1,619	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,177	-1,149	-1,143	-1,391	-1,518	-1,461	-1,123
Cash flows from investing activities:
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3	-4	-13	-11	31	-4	0	-0	-26	-214	180	-59	-7	-8	45	18	83
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,288	-1,180	-1,097	-1,696	-1,584	-1,219	-1,964	-2,000	-1,580	-	-	-	-	-	-	-	-
Purchase of property and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	8	21	72	90	1	0	18	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from payment of note receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,750	0	1,250	1,250	-	-	-	-
Cash flows from financing activities:
Borrowings under convertible secured note payable to shareholder
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,750	0	0	750	-	-	-	-
Payments on short-term notes payable
73	-	-	-	64	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	44	34	31	30	-	-	-	-	-	-	-	-
Net proceeds from issuance of common stock and warrants
-	-	-	-	11,415	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-72	-90	-1	0	-18	-	-	-	-	-	-	-	-	-	-	-	-
Payments on short-term notes payable
-	-	-	-	-	-	-	-46	-41	-47	-34	-40	-35	-45	-34	-44	-33	-46	-34	-44	-34	-44	-34	-44	-34	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from payment of stock subscription receivable
-	-	-	-	-	-	-	-	-	0	0	0	30	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Borrowings under convertible secured note payable to shareholder
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,000
Payments on short term notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	36	31	51	39	43	38
Restricted cash (receipts) released, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	25	35	82	50	98	-29	117	57	-51	86
Net cash provided by (used in) financing activities
-73	-73	-49	-129	11,351	9,439	12,385	1,463	-41	4,601	2,174	1,678	-4	939	949	2,596	-33	-	-	-	-	-	-	-	-	-	-	-	-	-	11,805	1,312	1,939	1,562	1,518	1,404	1,047
Net increase (decrease) in cash and cash equivalents
-3,895	-	-	-	9,140	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-34	-44	-34	-44	-34	9,229	3,875	23	5	-	-	-	-	-	-	-	-
Net increase in cash and cash equivalents
-	-	-	-	-	-	9,870	-817	-1,408	3,242	834	-86	-1,905	-1,024	-196	1,926	-1,653	-1,707	-1,381	-966	-1,395	-1,316	-1,133	-1,740	-1,637	8,008	1,900	-1,982	-1,575	-1,831	10,627	162	796	171	0	-56	-75
Operating cash flows from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-11	-144	163	-61	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental disclosure of cash flow information:
Par value of common stock issued for cashless exercise of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-
Interest paid
1	2	2	0	1	2	2	-2	4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid
-	-	-	-	-	-	-	-	-	-	-	-	0	1	1	0	0	4	-0	0	0	1	1	0	0	0	1	0	0	0	1	0	0	1	1	1	1
Non-cash investing and financing activities:
Borrowings under short term notes payable for prepaid expense
-	0	254	0	17	0	215	0	28	0	140	0	31	0	111	0	49	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock dividend on Series C preferred stock
661	-	-	-	413	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short-term note receivable from stockholder in exchange for the issuance of common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	77	0	48
Borrowings under short term notes payable for prepaid expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	49	0	108	0	50	-0	0	106	50	0	84	0	50	-	-	-	-
Par value of restricted shares issued
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock dividend on Series C preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Par value of common stock issued in exchange for services
-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Debt converted to Series C preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	2,538	0	8,737	-	-	-	-
Discount on note payable to shareholder for warrants issued
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	483	-	-	-	-
Fair market value of the 4,492,425 shares of common stock issued to Intrexon Corporation as a technology access fee
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Par value of forfeited stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	5.00	-	-	-	-
Series C Preferred Stock [Member]
Stock dividend on Series C preferred stock
-	-	-	-	-	-	-	0	58	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Series A Preferred Stock [Member]
Par value of common stock issued
-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Conversion of preferred stock into common stock
-	-	-	-	-	0	0	0	268	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-